Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04730999
Title Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer (CeLEBrATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Oncologico Italiano di Ricerca Clinica
Indications

lung small cell carcinoma

pulmonary neuroendocrine tumor

Therapies

Atezolizumab + Bevacizumab + Carboplatin + Etoposide

Age Groups: adult | senior
Covered Countries


No variant requirements are available.